Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Correction to: RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.

Lei FX, Jin L, Liu XY, Lai F, Yan XG, Farrelly M, Guo ST, Zhao XH, Zhang XD.

Cell Death Dis. 2019 Mar 5;10(3):225. doi: 10.1038/s41419-019-1301-2.

2.

Correction to: Natural product pectolinarigenin inhibits osteosarcoma growth and metastasis via SHP-1-mediated STAT3 signaling inhibition.

Zhang T, Li S, Li J, Yin F, Hua Y, Wang Z, Lin B, Wang H, Zou D, Zhou Z, Xu J, Yi C, Cai Z.

Cell Death Dis. 2018 Sep 5;9(9):902. doi: 10.1038/s41419-018-0911-4.

3.

RIP1 protects melanoma cells from apoptosis induced by BRAF/MEK inhibitors.

Lei FX, Jin L, Liu XY, Lai F, Yan XG, Farrelly M, Guo ST, Zhao XH, Zhang XD.

Cell Death Dis. 2018 Jun 7;9(6):679. doi: 10.1038/s41419-018-0714-7. Erratum in: Cell Death Dis. 2019 Mar 5;10(3):225.

4.

The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells.

Fujiwara J, Sowa Y, Horinaka M, Koyama M, Wakada M, Miki T, Sakai T.

Int J Oncol. 2016 Feb;48(2):854. doi: 10.3892/ijo.2015.3265. Epub 2015 Nov 25.

5.

Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A.

Mazzio EA, Soliman KFA.

Cancer Genomics Proteomics. 2018 Sep-Oct;15(5):349-364. doi: 10.21873/cgp.20094.

6.

Inhibition of HSP90 by AT13387 delays the emergence of resistance to BRAF inhibitors and overcomes resistance to dual BRAF and MEK inhibition in melanoma models.

Smyth T, Paraiso KHT, Hearn K, Rodriguez-Lopez AM, Munck JM, Haarberg HE, Sondak VK, Thompson NT, Azab M, Lyons JF, Smalley KSM, Wallis NG.

Mol Cancer Ther. 2014 Dec;13(12):2793-2804. doi: 10.1158/1535-7163.MCT-14-0452. Epub 2014 Oct 27.

7.

IRE1α-XBP1 pathway promotes melanoma progression by regulating IL-6/STAT3 signaling.

Chen C, Zhang X.

J Transl Med. 2017 Feb 21;15(1):42. doi: 10.1186/s12967-017-1147-2.

8.

[Corrigendum] Brassinin induces G1 phase arrest through increase of p21 and p27 by inhibition of the phosphatidylinositol 3-kinase signaling pathway in human colon cancer cells.

Izutani Y, Yogosawa S, Sowa Y, Sakai T.

Int J Oncol. 2016 Mar;48(3):1305. doi: 10.3892/ijo.2015.3315. Epub 2015 Dec 30.

PMID:
26718100
9.

Correction to: Heregulin β1 drives gefitinib-resistant growth and invasion in tamoxifen-resistant MCF-7 breast cancer cells.

Hutcheson IR, Knowlden JM, Hiscox SE, Barrow D, Gee JMW, Robertson JF, Ellis IO, Nicholson RI.

Breast Cancer Res. 2018 Aug 30;20(1):98. doi: 10.1186/s13058-018-0999-6.

10.

Correction: Toosendanin demonstrates promising antitumor efficacy in osteosarcoma by targeting STAT3.

Zhang T, Li J, Yin F, Lin B, Wang Z, Xu J, Wang H, Zuo D, Wang G, Hua Y, Cai Z.

Oncogene. 2019 Feb 15. doi: 10.1038/s41388-019-0738-1. [Epub ahead of print]

PMID:
30770898
11.

Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer-testis (CT-X) antigens.

Schirmer U, Fiegl H, Pfeifer M, Zeimet AG, Müller-Holzner E, Bode PK, Tischler V, Altevogt P.

BMC Cancer. 2018 Oct 29;18(1):1047. doi: 10.1186/s12885-018-4928-y.

12.

Correction: The Rho/ROCK pathway for lysophosphatidic acid-induced proteolytic enzyme expression and ovarian cancer cell invasion.

Jeong KJ, Park SY, Cho KH, Sohn JS, Lee J, Kim YK, Kang J, Park CG, Han JW, Lee HY.

Oncogene. 2019 Mar 29. doi: 10.1038/s41388-019-0769-7. [Epub ahead of print]

PMID:
30926886
13.

Correction to: NFATc2 is an intrinsic regulator of melanoma dedifferentiation.

Perotti V, Baldassari P, Molla A, Vegetti C, Bersani I, Maurichi A, Santinami M, Anichini A, Mortarini R.

Oncogene. 2019 Jan 28. doi: 10.1038/s41388-019-0679-8. [Epub ahead of print]

PMID:
30692631
14.

Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.

Xiao J, Egger ME, McMasters KM, Hao H.

BMC Cancer. 2018 Jun 22;18(1):675. doi: 10.1186/s12885-018-4583-3.

15.

Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation.

Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DP, Darzynkiewicz Z.

Cancer Res. 2000 Aug 1;60(15):4139-45.

16.

Author Correction: Fermiology and electron dynamics of trilayer nickelate La4Ni3O10.

Li H, Zhou X, Nummy T, Zhang J, Pardo V, Pickett WE, Mitchell JF, Dessau DS.

Nat Commun. 2018 May 11;9(1):1958. doi: 10.1038/s41467-018-04105-y.

17.

Author Correction: ZSCAN10 expression corrects the genomic instability of iPSCs from aged donors.

Skamagki M, Correia C, Yeung P, Baslan T, Beck S, Zhang C, Ross CA, Dang L, Liu Z, Giunta S, Chang TP, Wang J, Ananthanarayanan A, Bohndorf M, Bosbach B, Adjaye J, Funabiki H, Kim J, Lowe S, Collins JJ, Lu CW, Li H, Zhao R, Kim K.

Nat Cell Biol. 2019 Apr;21(4):531-532. doi: 10.1038/s41556-018-0269-y.

PMID:
30643186
18.

BH3-mimetic gossypol-induced autophagic cell death in mutant BRAF melanoma cells with high expression of p21Cip¹.).

Jang GH, Lee M.

Life Sci. 2014 Apr 25;102(1):41-8. doi: 10.1016/j.lfs.2014.02.036. Epub 2014 Mar 10.

PMID:
24625733
19.
20.

Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.

Blazar BR, Widmer MB, Soderling CC, Urdal DL, Gillis S, Robison LL, Vallera DA.

Blood. 1988 Feb;71(2):320-8.

Supplemental Content

Support Center